content_image/172427.jpg
## Stopping Deadly Infections 

Nearly 125  years ago, Johnson & Johnson pioneered ready-to-use surgical dressings that helped keep pathogens from infecting wounds. Now, Advanced Sterilization Products (ASP), a division of Ethicon, Inc., is pioneering the reduction of pathogens from health care settings with GLOSAIR ™  area disinfection products. 

The World Health Organization estimates that in Europe, more than 4 million patients are affected by 

<img src='content_image/172427.jpg'>

approximately  4.5  million episodes of health care- associated infections (HAIs) each year, causing 16  million extra days of hospital stay and 37,000  deaths. Another conse- quence: HAIs place significant cost pressure on hospitals. 

GLOSAIR ™  helps reduce the risk of HAIs and is on course to become a new standard of care. Studies show that this safe and user-friendly technology—a hydrogen peroxide dry-mist system—is a more effective method of disinfecting health care settings, following cleaning, than sole reliance on manual application of tradi- tional disinfectants. 

“These machines have helped us maintain a good standard of cleaning and manage a safe patient environment,” says Paul Andrews, Housekeeping Manager, Dorset County 

Hospital, England. The local emergency hospital has used GLOSAIR ™ 400  Systems to help reduce HAI rates. “We’ve achieved one of the lowest MRSA rates in the National Health System since adding GLOSAIR ™  to our infection- prevention practices,” says Andrews. 

Since acquiring Gloster Europe in 2009 , ASP has leveraged its ability to take GLOSAIR ™  to more markets. A global rollout began with launches throughout Europe in 2010 ; plans are to launch in the U.S. in 2011. 

## INFECTION PREVENTION 

Paul Andrews and colleague Carrole White use a GLOSAIR ™ 400  System to help reduce health care-associated infections at Dorset County Hospital in England. 

## A World Without Limits for People With Diabetes 

Diabetes is a global epidemic that’s increasing at an alarming rate. “One of the biggest challenges people with diabetes face is keeping their blood glucose levels in range,” says Kenneth Moritsugu, M.D., Vice President, LifeScan, Inc. “Better control can lead to fewer long-term complica- tions and ultimately can lower health care costs.” 

That’s why the Diabetes Care franchise remains dedi- cated to creating a world without limits for people with diabetes, delivering innovative products and tools that are easy for health care providers to teach and give patients more helpful information. 

In 2010 , LifeScan began a global rollout of the OneTouch $^{®}$ Verio$^{™}$ Blood Glucose Monitoring System. This accurate, easy-to-use system requires no coding and filters out many common interferences, reducing the chance for error. The system was test-marketed in the Netherlands with patients on insulin therapy and launched in Australia and Europe. Other markets will follow in 2011 . 

Also in 2010 , Animas Corporation, a leader in insulin pump systems, partnered with the Juvenile Diabetes Research Foundation to develop a first-generation partially automated glucose management system, a step toward the goal of revolutionizing treatment of type 1  diabetes. 

